Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02855944
Title ARIEL4: A Study of Rucaparib Versus Chemotherapy BRCA Mutant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients
Recruitment Active, not recruiting
Gender female
Phase Phase III
Variant Requirements No
Sponsors Clovis Oncology, Inc.
Indications

fallopian tube cancer

ovary epithelial cancer

peritoneum cancer

Therapies

Cisplatin

Rucaparib

Carboplatin

Gemcitabine

Paclitaxel

Age Groups: adult | senior
Covered Countries USA | CAN


No variant requirements are available.